elmiradaily.com
U.S. Biosimilars Market to Expand at 54.7% CAGR; Increasing Demand from the Unmet Populace to Create Growth Opportunities | Fortune Business Insights - Elmira Daily
The U.S. biosimilars market will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by Fortune Business Insights, titled, “Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026,” the U.S. biosimilars market is projected to reach US$ 17,696.0 Mn by 2026. The report provides valuable insights into …